Abstract
Metastatic melanoma lesions often are unresectable due to their size and/or location near critical structures. These lesions represent a significant challenge for the oncologist, because radiation therapy and chemotherapy are infrequently successful in halting tumor growth. Of primary concern is the fact that these lesions are usually painful and present a cosmetic dilemma. We hypothesized that the development of a silicon-based nano-device capable of delivering antitumor compounds (e.g. immune modulators), locally, at a constant rate, to the tumor microenvironment could avoid the toxicity of systemic administration and the inconvenience of frequent clinic visits for local injections. Because of its diminutive size, such a device could be implanted using a minimally invasive procedure in close proximity to unresectable melanoma lesions. The current report uses interferon alpha-2b (IFN-α) as a model antitumor agent, since it is commonly used in the treatment of malignant melanoma and metastatic renal cell carcinoma. In this system, IFN-α is delivered directly to the tumor microenvironment by a novel nanochannel delivery system (nDS) that is capable of zero order release of small molecules. We have demonstrated that the IFN-α released from the nDS is functionally active on both host immune cells and a human melanoma cell line in vitro. This drug delivery platform could be used to develop alternative strategies for the treatment of unresectable tumors.
Similar content being viewed by others
References
C.M. Balch, Biologic Therapy (Quality Medical Publishing, St. Louis, 1998), p. 419.
F. Belardelli, M. Ferrantini, E. Proietti, and J.M. Kirkwood, Cytokine Growth Factor Rev 13, 119 (2002).
D.D. Breimer, J Control Release 62, 3 (1999).
W. Chu, T. Huen, J. Tu, and M. Ferrari, Proc SPIE 2978, 111 (1996).
J.E. Darnell, I.M. Kerr, and G.R. Stark, Science 264, 1415 (1994).
T.A. Desai, W.H. Chu, G. Rasi, P. Sinibaldi-Vallebona, E. Guarino, and M. Ferrari, Biomed Microdevices 1, 131 (1999).
S.J. Haque and B.R. Williams, Semin Oncol 25(Suppl 1), 14 (1998).
D. Ikic, S. Spaventi, I. Padovan, Z. Kusic, V. Cajkovac, D. Ivankovic, N. Dakovic, and P. Nola, Int. J. Dermatol 34, 872 (1995).
S.H. Kim, B. Cohen, D. Novick, and M. Rubinstein, Gene 196, 279 (1997).
J.M. Kirkwood, M.S. Ernstoff, C.A. Davis, M. Reiss, R. Ferraresi, and S. Rudnick, Ann. Intern. Med. 103, 32 (1985).
J.M. Kirkwood, M.H. Strawderman, M.H. Ernstoff, T.J. Smith, E.C. Borden, and R.H. Blum, J. Clin. Oncol. 14, 7 (1996).
E.A. Klausner, S. Eyal, E. Lavy, M. Friedman, and A. Hoffman, J. Control Release 88, 117 (2003).
D.A. LaVan, T. McGuire, and R. Langer, Nat. Biotechnol 21(10), 1184 (2003).
S.S. Legha, Cancer 57, 1675 (1986).
M.B. Lens and M. Dawes, J. Clin. Oncol. 20, 1818 (2002).
G.B. Lesinski, S.V. Kondadasula, T. Crespin, L. Shen, K. Kendra, M.J. Walker, and W.E. Carson, J. Natl. Cancer Inst. 96, 1331 (2004).
S.N. Magonov and M. Whangbo, Surface Analysis with STM and AFM: Experimental and Theoretical Aspects of Image Analysis (Weinheim, NewYork, 1996).
F. Martin, R. Walczak, A. Boiarski, M. Cohen, T. West, C. Cosentino, and M. Ferrari, J. Control Release (in press, 2004).
N.P. Nguyen, B. Levinson, S. Dutta, U. Karlsson, A. Alfieri, C. Childress, and S. Sallah, Melanoma Res. 13, 67 (2003).
R. Parihar, J. Dierksheide, Y. Hu, and W.E. Carson, J. Clin. Invest 110, 983 (2002).
C.R. Rossi, M. Foletto, P. Pilati, S. Mocellin, and M. Lise, Semin. Oncol. 29(4), 400 (2002).
J.T. Santini, M.J. Cima, and R. Langer, Nature 397, 335 (1999).
P.M. Sinha, G. Valco, S. Sharma, X. Liu, and M. Ferrari, Nanotechnology 15, S585 (2004).
J.K. Tu, T. Huen, R. Szema, and M. Ferrari, Biomed. Microdevices 1(2), 113 (1999).
P. von Wussow, B. Block, F. Hartmann, and H. Deicher, Cancer 61, 1071 (1988).
G. Voskerician, M.S. Shive, R.S. Shawgo, H. von Recum, J.M. Anderson, M.J. Cima, and R. Langer, Biomaterials 24(11), 1959 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lesinski, G.B., Sharma, S., Varker, K.A. et al. Release of Biologically Functional Interferon-Alpha from a Nanochannel Delivery System. Biomed Microdevices 7, 71–79 (2005). https://doi.org/10.1007/s10544-005-6174-8
Issue Date:
DOI: https://doi.org/10.1007/s10544-005-6174-8